ARCA biopharma Announces Fiscal Year 2017 Financial Results and Provides Corporate Update

Author's Avatar
Mar 23, 2018
Article's Main Image

ARCA is Requesting a Meeting with the U.S. FDA for the Second Quarter of 2018 to Review Gencaro Phase 2 Data and Future Development Plan